Citation Impact
Citing Papers
Phase IIB Multicenter Trial of Vorinostat in Patients With Persistent, Progressive, or Treatment Refractory Cutaneous T-Cell Lymphoma
2007 Standout
Viral Vectors in Gene Therapy: Where Do We Stand in 2023?
2023
Gene transfer of master autophagy regulator TFEB results in clearance of toxic protein and correction of hepatic disease in alpha‐1‐anti‐trypsin deficiency
2013
Screening Libraries to Discover Molecular Design Principles for the Targeted Delivery of mRNA with One-Component Ionizable Amphiphilic Janus Dendrimers Derived from Plant Phenolic Acids
2023 StandoutNobel
Plasma 1,25-Dihydroxy- and 25-Hydroxyvitamin D and Subsequent Risk of Prostate Cancer
2004
Signals from the lysosome: a control centre for cellular clearance and energy metabolism
2013 Standout
Diet and prostate cancer risk in a cohort of smokers, with a specific focus on calcium and phosphorus (Finland)
2000
Vitamin D: A millenium perspective
2003 Standout
High Prevalence of Vitamin D Inadequacy and Implications for Health
2006 Standout
Monitoring technologies in the neonatal intensive care unit: implications for the detection of necrotizing enterocolitis
2010
Newborn Hearing Screening — A Silent Revolution
2006 Standout
Sunlight and Vitamin D
2013 Standout
The role of vitamin D in prostate cancer
2001
Applications of CRISPR-Cas Enzymes in Cancer Therapeutics and Detection
2018 StandoutNobel
Maternal intake of vitamin D during pregnancy and risk of recurrent wheeze in children at 3 y of age
2007 Standout
Vitamin D Deficiency
2007 Standout
Vitamin D and Prostate Cancer: Biologic Interactions and Clinical Potentials
1998
Epidemiology of Prostate Cancer
2019 Standout
Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes
2006 Standout
The development of androgen-independent prostate cancer
2001 Standout
Prevalence of permanent childhood hearing impairment in the United Kingdom and implications for universal neonatal hearing screening: questionnaire based ascertainment studyCommentary: Universal newborn hearing screening: implications for coordinating and developing services for deaf and hearing impaired children
2001
Delivery technologies for cancer immunotherapy
2019 Standout
Sensorineural hearing loss in children
2005 Standout
Dairy products, calcium, and prostate cancer risk in the Physicians’ Health Study
2001
Non-viral vectors for gene-based therapy
2014 Standout
Histone deacetylases and cancer: causes and therapies
2001 Standout
Necrotizing Enterocolitis
2011 Standout
In vivo genome editing using Staphylococcus aureus Cas9
2015 StandoutNature
Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease
2004 Standout
Antiproliferative Action of Vitamin D
2002
Prospective Study of Predictors of Vitamin D Status and Cancer Incidence and Mortality in Men
2006 Standout
Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges
2011
The role of vitamin D in reducing cancer risk and progression
2014
Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells
2001 Standout
Vitamin D Deficiency in Children and Its Management: Review of Current Knowledge and Recommendations
2008 Standout
Neuroprotective peptide drug delivery and development: potential new therapeutics
2001
Progress and prospects: immune responses to viral vectors
2009
Negative Control of p53 by Sir2α Promotes Cell Survival under Stress
2001 Standout
Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: A longitudinal, nested case‐control study in the Nordic countries
2003
CYP24A1 splice variants—Implications for the antitumorigenic actions of 1,25-(OH)2D3 in colorectal cancer
2010
Vitamin D deficiency: a worldwide problem with health consequences
2008 Standout
Human prostate cells synthesize 1,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3.
1998
Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)
2006 Standout
Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo.
2000
1 alpha,25-Dihydroxyvitamin D (calcitriol) inhibits the invasiveness of human prostate cancer cells.
1997
Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases
2012 Standout
Projected Cost-Effectiveness of Statewide Universal Newborn Hearing Screening
2002
Vitamin D and prostate cancer
2001
Ionizable lipid nanoparticles deliver mRNA to pancreatic β cells via macrophage-mediated gene transfer
2023 StandoutNobel
Vitamin D and Prostate Cancer
2002
TREATMENT OF EARLY RECURRENT PROSTATE CANCER WITH 1,25-DIHYDROXYVITAMIN D3 (CALCITRIOL)
1998
Calcium, dairy products, and risk of prostate cancer in a prospective cohort of United States men.
2003
Adverse Health Consequences of Performance-Enhancing Drugs: An Endocrine Society Scientific Statement
2013 Standout
The Role of Vitamin D in Cancer Prevention
2005 Standout
Natural product and natural product derived drugs in clinical trials
2014 Standout
Treatment of early recurrent prostate cancer with 1,25-dihydroxyvitamin D3 (calcitriol)
1998
The Control of Prostate-Specific Antigen Expression and Gene Regulation by Pharmacological Agents
2001
The Colorado Newborn Hearing Screening Project, 1992–1999: On the Threshold of Effective Population-Based Universal Newborn Hearing Screening
2002
Exosomes as drug delivery vehicles for Parkinson's disease therapy
2015 Standout
Vitamin D receptor polymorphisms and prostate cancer
2000
Cell-Type Specific Features of Circular RNA Expression
2013 Standout
Novel strategies and therapeutics for the treatment of prostate carcinoma
2000
Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group
2008 Standout
Inhibition of prostate cancer metastasis in vivo: a comparison of 1,23-dihydroxyvitamin D (calcitriol) and EB1089.
1999
Works of Gary Stapleton being referenced
Pseudo-hydrodynamic Delivery of Helper-dependent Adenoviral Vectors into Non-human Primates for Liver-directed Gene Therapy
2007
Efficient, Long-term Hepatic Gene Transfer Using Clinically Relevant HDAd Doses by Balloon Occlusion Catheter Delivery in Nonhuman Primates
2008
Transgene Expression up to 7 Years in Nonhuman Primates Following Hepatic Transduction with Helper-Dependent Adenoviral Vectors
2013
Vitamin D receptor expression, 24-hydroxylase activity, and inhibition of growth by 1alpha,25-dihydroxyvitamin D3 in seven human prostatic carcinoma cell lines.
1995
Mesenteric oxygen desaturation in an infant with congenital heart disease and necrotizing enterocolitis.
2007
Persistent Central Diabetes Insipidus Presenting in a Very Low Birth Weight Infant Successfully Managed With Intranasal dDAVP
2000